Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0001140361-16-087649

Director sold 42,550 shares at $11.71 ($498,078)

From the SEC's structured data for this filing

Trades in this filing

SHANNON TIMOTHY M · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-11-22 Sale : show line 1 in the form −42,550 $11.71 $498,078 3,704,926 I
Open-market sales · 42,550 sh · avg $11.71 · $498,078
Loading xslF345X03/doc1.xml…